Australia: A recent multicentre audit conducted in Queensland, Australia, has provided compelling real-world evidence ...

In phase 2 of the FORWARD study, 83% of participants with type 1 diabetes achieved insulin independence a year after receiving zimislecel (formerly VX-880), an islet cell therapy developed ...